PND35 Belgian Cost-Utility Analysis of Gilenya®...

PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod) in the Management of Adults with Active Relapsing Remitting Multiple Sclerosis

S. Drieskens, K. Moeremans
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2011.08.501
File:
PDF, 60 KB
english, 2011
Conversion to is in progress
Conversion to is failed